Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c943 |
|---|---|
| Identifier | NCT05156125 |
| Trial Title | VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: VTX002|DRUG: VTX002|DRUG: Placebo |
Participant Information
| Sponsor | Oppilan Pharma Ltd |
|---|---|
| City | Garden Grove |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-11-30 |
|---|---|
| Primary Completion Date | 2023-08-30 |
| Completion Date | 2026-08-31 |